Alignment Healthcare COO sells shares for taxes

Alignment Healthcare COO Sebastian Burzacchi reported an open-market sale of 15,361 shares of common stock.

Accepted by SEC EDGAR 03/19/2026 - 06:44 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Alignment Healthcare COO Sebastian Burzacchi reported an open-market sale of 15,361 shares of common stock. The shares were sold at a weighted-average price of $17.84 per share, in multiple trades between $17.40 and $18.24. According to the disclosure, the sale was required to cover tax withholding obligations tied to the vesting of restricted stock units and is described as non-discretionary. After this transaction, Burzacchi directly holds 258,630 shares.

Insider Trade Summary

Net Seller: 15,361 shares

Net Sell 1 txn

Insider Burzacchi Sebastian

Role COO - Mgmt Services Org

Sold 15,361 shs ($274K)

Type	Security	Shares	Price	Value
Sale	Common Stock	15,361	$17.84	$274K

Holdings After Transaction: Common Stock — 258,630 shares (Direct)

Footnotes (2)

1. F1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
2. F2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Alignment Healthcare (ALHC) report for Sebastian Burzacchi?

Sebastian Burzacchi, COO – Management Services Organization at Alignment Healthcare, reported selling 15,361 shares of common stock. The filing explains these shares were sold solely to cover tax withholding obligations arising from vesting restricted stock units, rather than from a discretionary trading decision.

At what price did Sebastian Burzacchi sell Alignment Healthcare (ALHC) shares?

The reported weighted-average sale price was $17.84 per share. The Form 4 notes the shares were sold in multiple transactions, with individual prices ranging from $17.40 to $18.24, and offers to provide full price breakdowns upon request to the company or regulators.

How many Alignment Healthcare (ALHC) shares does Sebastian Burzacchi hold after this Form 4 sale?

Following the reported sale, Sebastian Burzacchi directly owns 258,630 shares of Alignment Healthcare common stock. This figure reflects his remaining direct holdings after selling 15,361 shares to satisfy tax withholding obligations related to the vesting of restricted stock units.

Was Sebastian Burzacchi’s Alignment Healthcare (ALHC) share sale a discretionary trade?

No, the Form 4 states the sale was not a discretionary trade. The shares were sold specifically to cover tax withholding obligations triggered by the vesting of restricted stock units, indicating the transaction was mechanical rather than a voluntary decision to reduce exposure.

Why were Alignment Healthcare (ALHC) shares sold across a price range in Burzacchi’s Form 4?

The filing reports a weighted-average price of $17.84 because shares were sold in multiple trades between $17.40 and $18.24. The insider undertakes to provide detailed breakdowns of the number of shares sold at each price within that range upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burzacchi Sebastian

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CALIFORNIA 92868

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	COO - Mgmt Services Org

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/18/2026		S		15,361(1)	D	$17.84(2)	258,630	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Sebastian Burzacchi	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)